top of page

Dying Too Soon Should be What You Worry About: The Novel Coronavirus

Dr. Trempe taught me that the only important "endpoint" in any clinical trial is an increase in early mortality. Today, the drug companies use "surrogate endpoints" to rationalize many of the studies that lead to a new medication.

If you die sooner than your biological life expectancy, you can be sure you have a much higher chance of "morbidity," the medical term for disease.

Based on Dr. Trempe's teachings, our Chronic Disease Temperature biomarker panel and algorithm is an early mortality barometer.

What does this have to do with the novel coronavirus? It's not 100% fatal. It's not even 1% fatal. And if you are truly healthy, it probably not even 0.01% fatal. We will wait for more testing data to be sure. However, this data is (or should be) the foundation for public health policy.

Dr. Ioannidis (MD) from Stanford - a true data expert - and critic of how pharmaceutical companies run trials - gives estimates for COVID-19 death rates that are about the same as yearly influenza. He is well respected globally and one of his many research papers titled, "Why Most Published Research Findings Are False," is the most sited of any PLOS (Public Library of Science) article.

Here is a long and short video by Dr. Ioannidis:

Long Version:

Short Version:

Please watch this video that explains the cytokine storm and how the severity of the storm may be impacted by your current state of health.


Get healthy, stay alive!


If you don't have access to testing, your next best action is to take any of these surveys:

Free 10 minute COVID-19 consults are now available. Write to me at and provide your phone number.


Stay Well

Thomas J. Lewis, Ph.D.

51 views0 comments

Recent Posts

See All


bottom of page